ES2054148T3 - Agentes terapeuticos de enfermedades oseas metabolicas. - Google Patents
Agentes terapeuticos de enfermedades oseas metabolicas.Info
- Publication number
- ES2054148T3 ES2054148T3 ES90111100T ES90111100T ES2054148T3 ES 2054148 T3 ES2054148 T3 ES 2054148T3 ES 90111100 T ES90111100 T ES 90111100T ES 90111100 T ES90111100 T ES 90111100T ES 2054148 T3 ES2054148 T3 ES 2054148T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- carbons
- therapeutic agents
- indicates
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 208000029725 Metabolic bone disease Diseases 0.000 title 1
- -1 AMINO GROUP Chemical group 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 abstract 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical group C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical group NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- BWHOZHOGCMHOBV-BQYQJAHWSA-N trans-benzylideneacetone Chemical group CC(=O)\C=C\C1=CC=CC=C1 BWHOZHOGCMHOBV-BQYQJAHWSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
ES DESCRITO EL NUEVO USO DE DERIVADOS DE ACIDO ANTRANILICO CICLICO DE LA SIGUIENTE FORMULA, EN DONDE R1,R2 Y R3 CADA UNO INDEPENDIENTEMENTE INDICAN HIDROGENO CLORO, UN GRUPO ALQUIL REDUCIDO QUE TIENE DE 1 A 3 CARBONOS, UN GRUPO ALCOXI REDUCIDO QUE TIENE DE 1 A 3 CARBONOS, UN GRUPO AMINO, UN GRUPO NITRO, UN GRUPO HIDROXI, UN GRUPO SULFONAMIDA, UN GRUPO TRIFLUOROMETIL, UN GRUPO CIANO, UN GRUPO CARBOXIL, UN GRUPO CARBAMOIL, UN GRUPO ACETIL, UN GRUPO BENZOILMETIL QUE DEBE SER SUSTITUIDO, UN GRUPO METILTIO, UN GRUPOFENILETINIL QUE DEBE SER SUSTITUIDO, UN GRUPO ALCANOILAMINO QUE TIENE DE 1 A 3 CARBONOS, UN GRUPO BENZOILAMINO QUE DEBE SER SUSTITUIDO, UN GRUPO ALQUILSULFONILAMINO QUE TIENE DE 1 A 3 CARBONOS O UN GRUPO FENILSULFONILAMINO QUE DEBE SER SUSTITUIDO; R4 Y R5 CADA UNO INDEPENDIENTEMENTE INDICAN HIDROGENO, UN GRUPO ALQUIL REDUCIDO QUE TIENE DE 1 A 3 CARBONOS, UN GRUPO CIANO, UN GRUPO CARBOXIL, UN GRUPO HIDROXIMETIL, UN GRUPO FENIL QUE DEBE SER SUTITUIDO O UN GRUPO BENZOIL; R6 INDICA HIDROGENO, UN GRUPO ALQUIL REDUCIDO QUE TIENE DE 1 A 3 CARBONOS O UN GRUPO BENZIL; X INDICA UN GRUPO METILENO, OXIGENO, AZUFRE, UN GRUPO SULFINIL O SULFONIL; SU ACIDO O SUS SALES ALCALI COMO AGENTES TERAPEUTICOS PARA ENFERMEDADES METABOLICAS DE HUESOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14998889 | 1989-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2054148T3 true ES2054148T3 (es) | 1994-08-01 |
Family
ID=15487012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES90111100T Expired - Lifetime ES2054148T3 (es) | 1989-06-13 | 1990-06-12 | Agentes terapeuticos de enfermedades oseas metabolicas. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5124325A (es) |
| EP (1) | EP0402859B1 (es) |
| KR (1) | KR910000150A (es) |
| AU (1) | AU623268B2 (es) |
| DE (1) | DE69000791T2 (es) |
| ES (1) | ES2054148T3 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3209568B2 (ja) * | 1991-04-16 | 2001-09-17 | 杏林製薬株式会社 | 新規環状アミノフェニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤 |
| EP0634169B1 (en) * | 1993-06-29 | 2000-01-05 | Takeda Chemical Industries, Ltd. | Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
| FR2714381B1 (fr) * | 1993-12-29 | 1996-02-02 | Pharmascience Lab | Dérivés de la benzoxazine, leurs procédés d'obtention et leur utilisation en tant que médicaments . |
| US6180640B1 (en) | 1998-06-25 | 2001-01-30 | Sepracor, Inc. | Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0696556B2 (ja) * | 1987-05-26 | 1994-11-30 | キッセイ薬品工業株式会社 | ２−キノロン誘導体 |
| JPS6422873A (en) * | 1987-07-16 | 1989-01-25 | Maruko Pharmaceutical Co | 1,4-benzoxazine derivative |
| US4956372A (en) * | 1987-10-02 | 1990-09-11 | Kyorin Pharmaceutical Co., Ltd. | Cyclic anthranilic acid derivatives and process for their preparation |
-
1990
- 1990-06-08 US US07/536,007 patent/US5124325A/en not_active Expired - Fee Related
- 1990-06-12 DE DE9090111100T patent/DE69000791T2/de not_active Expired - Fee Related
- 1990-06-12 AU AU57028/90A patent/AU623268B2/en not_active Ceased
- 1990-06-12 KR KR1019900008582A patent/KR910000150A/ko not_active Application Discontinuation
- 1990-06-12 ES ES90111100T patent/ES2054148T3/es not_active Expired - Lifetime
- 1990-06-12 EP EP90111100A patent/EP0402859B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0402859B1 (en) | 1993-01-20 |
| AU5702890A (en) | 1990-12-20 |
| DE69000791D1 (de) | 1993-03-04 |
| US5124325A (en) | 1992-06-23 |
| EP0402859A2 (en) | 1990-12-19 |
| EP0402859A3 (en) | 1991-08-07 |
| DE69000791T2 (de) | 1993-08-12 |
| KR910000150A (ko) | 1991-01-28 |
| AU623268B2 (en) | 1992-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003414D0 (no) | Anvendelse av PPAR-<ypsilon> aktivatorer i dermatologi | |
| ES2088006T3 (es) | Composiciones farmaceuticas osteoinductivas. | |
| DE69942365D1 (de) | Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben | |
| ES2040838T3 (es) | Compuestos piperazinil-heterociclicos. | |
| ES2176252T3 (es) | Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos. | |
| ATE320804T1 (de) | Behandlung negativer und kognitiver symptome der schizophrenie mit antagonisten der glycinaufnahme | |
| AR008853A1 (es) | Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos | |
| ATE86247T1 (de) | 3-indolpyruvsaeure-derivate und deren verwendung als arznemittel. | |
| ES2098721T3 (es) | Tetrahidroisoquinoleinas substituidas y su uso como agentes terapeuticos. | |
| AR004516A1 (es) | Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| ATE319823T1 (de) | Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen | |
| ES2178779T3 (es) | Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores. | |
| DE69724777D1 (de) | Pentafluorobenzensulfonamiden und analoge | |
| HUP0002272A2 (hu) | Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| DE3650518D1 (de) | Beta-Lactamantibiotika, Verfahren zur Herstellung und ihre Verwendung als und in Arzneimitteln | |
| DE60018213D1 (de) | Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons | |
| TR199902334T2 (xx) | Psikotik bozukluklar�n tedavisi veya profilaksisi i�in mirtazapin ve antipsikotik ajanlar�n yeni terap�tik kombinasyonlar�. | |
| ES2055037T3 (es) | Derivados de 4-amino-3-acil-quinolina y su uso como inhibidores de la secrecion de acido gastrico. | |
| ES2058374T3 (es) | Amidas de acidos 1-cloro-pirimidinil-1h-1,2,4-triazol-3-sulfonicos, a procedimientos para su preparacion y a su utilizacion como agentes con efecto herbicida. | |
| ES2054148T3 (es) | Agentes terapeuticos de enfermedades oseas metabolicas. | |
| BR0010151A (pt) | Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais | |
| DE69419640D1 (de) | Pharmakologische Verwendung von 5-Aminophthaloylhydrazide; ihre Zusammensetzung und Anwendung | |
| ATE172721T1 (de) | Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren | |
| ES2056639T3 (es) | Procedimiento para la transformacion del acido (benzoil-3 fenil)-2 propionico-r(-) en isomero s(+). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 402859 Country of ref document: ES |